Guild Investment Management, Inc. Gamida Cell Ltd. Transaction History

Guild Investment Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 26, 2021	BUY	$3.85 - $6.44 $69,300 - $115,920	18,000 New	18,000 $71,000
Q2 2021 Jul 28, 2021	SELL	$5.85 - $8.33 $87,750 - $124,950	-15,000 Closed	0 $0
Q1 2021 Apr 19, 2021	BUY	$7.8 - $12.43 $117,000 - $186,450	15,000 New	15,000 $121,000

11.4M

235K

70.5K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Guild Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Guild Investment Management, Inc. with notifications on news.